Abstract:Abstract Background CRISPR-Cas systems, which provide adaptive immunity against foreign nucleic acids in prokaryotes, can serve as useful molecular tools for multiple applications in genome engineering. Diverse CRISPR-Cas systems originating from distinct prokaryotes function through a common mechanism involving the assembly of small crRNA molecules and Cas proteins into a ribonucleoprotein (RNP) effector complex, and formation of an R-loop structure upon binding to the target DNA. Extensive research on the I-E subtype established the prototypical mechanism of DNA interference in type I systems, where the coordinated action of a ribonucleoprotein Cascade complex and Cas3 protein destroys foreign DNA. However, diverse protein composition between type I subtypes suggests differences in the mechanism of DNA interference that could be exploited for novel practical applications that call for further exploration of these systems. Results Here we examined the mechanism of DNA interference provided by the type I-F1 system from Aggregatibacter actinomycetemcomitans D7S-1 (Aa). We show that functional Aa-Cascade complexes can be assembled not only with WT spacer of 32 nt but also with shorter or longer (14–176 nt) spacers. All complexes guided by the spacer bind to the target DNA sequence (protospacer) forming an R-loop when a C or CT protospacer adjacent motif (PAM) is present immediately upstream the protospacer (at −1 or −2,−1 position, respectively). The range of spacer and protospacer complementarity predetermine the length of the R-loop; however, only R-loops of WT length or longer trigger the nuclease/helicase Cas2/3, which initiates ATP-dependent unidirectional degradation at the PAM-distal end of the WT R-loop. Meanwhile, truncation of the WT R-loop at the PAM-distal end abolishes Cas2/3 cleavage. Conclusions We provide a comprehensive characterisation of the DNA interference mechanism in the type I-F1 CRISPR-Cas system, which is different from the type I-E in a few aspects. First, DNA cleavage initiation, which usually happens at the PAM-proximal end in type I-E, is shifted to the PAM-distal end of WT R-loop in the type I-F1. Second, the R-loop length controls on/off switch of DNA interference in the type I-F1, while cleavage initiation is less restricted in the type I-E. These results indicate that DNA interference in type I-F1 systems is governed through a checkpoint provided by the Cascade complex, which verifies the appropriate length for the R-loop.

Structural variation of types IV-A1- and IV-A3-mediated CRISPR interference

DNA interference is controlled by R-loop length in a type I-F1 CRISPR-Cas system

Structure and mechanism of the type I-G CRISPR effector

Visualization of Type IV-A1 CRISPR-mediated repression of gene expression and plasmid replication

Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans

Structure and genome editing of type I-B CRISPR-Cas

Type IV-A CRISPR-Csf complex: Assembly, dsDNA targeting, and CasDinG recruitment

Structural Basis for AcrVA4 Inhibition of Specific CRISPR-Cas12a

Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications

Structural rearrangements allow nucleic acid discrimination by type I-D Cascade

RNA targeting and cleavage by the type III-Dv CRISPR effector complex

Structural basis for the activity of the type VII CRISPR-Cas system

Structure and function of a bacterial type III-E CRISPR–Cas7-11 complex

Unravelling the structural and mechanistic basis of CRISPR–Cas systems

Structural basis for inhibition of an archaeal CRISPR–Cas type I-D large subunit by an anti-CRISPR protein

Structural basis of target DNA recognition by CRISPR-Cas12k for RNA-guided DNA transposition

Structural basis for the type I-F Cas8-HNH system

Dna Targeting By Subtype I-D Crispr-Cas Shows Type I And Type Iii Features

Cas3/I-C mediated target DNA recognition and cleavage during CRISPR interference are independent of the composition and architecture of Cascade surveillance complex

Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex